Chapter/Section Purchase

1 Drug Coated Stent Market Overview
1.1 Product Overview and Scope of Drug Coated Stent
1.2 Drug Coated Stent Segment by Type
1.2.1 Global Drug Coated Stent Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Everolimus-Coated Stent
1.2.3 Zotarolimus-Coated Stent
1.2.4 Ridaforolimus-Coated Stent
1.2.5 SYNERGY Coated Stent
1.2.6 Orsiro Coated Stent
1.3 Drug Coated Stent Segment by Application
1.3.1 Global Drug Coated Stent Sales Comparison by Application: (2022-2028)
1.3.2 Angioplasty
1.3.3 Restenosis
1.4 Global Drug Coated Stent Market Size Estimates and Forecasts
1.4.1 Global Drug Coated Stent Revenue 2017-2028
1.4.2 Global Drug Coated Stent Sales 2017-2028
1.4.3 Drug Coated Stent Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drug Coated Stent Market Competition by Manufacturers
2.1 Global Drug Coated Stent Sales Market Share by Manufacturers (2017-2022)
2.2 Global Drug Coated Stent Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Drug Coated Stent Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Drug Coated Stent Manufacturing Sites, Area Served, Product Type
2.5 Drug Coated Stent Market Competitive Situation and Trends
2.5.1 Drug Coated Stent Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug Coated Stent Players Market Share by Revenue
2.5.3 Global Drug Coated Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Coated Stent Retrospective Market Scenario by Region
3.1 Global Drug Coated Stent Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Drug Coated Stent Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Drug Coated Stent Market Facts & Figures by Country
3.3.1 North America Drug Coated Stent Sales by Country
3.3.2 North America Drug Coated Stent Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Drug Coated Stent Market Facts & Figures by Country
3.4.1 Europe Drug Coated Stent Sales by Country
3.4.2 Europe Drug Coated Stent Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug Coated Stent Market Facts & Figures by Region
3.5.1 Asia Pacific Drug Coated Stent Sales by Region
3.5.2 Asia Pacific Drug Coated Stent Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Drug Coated Stent Market Facts & Figures by Country
3.6.1 Latin America Drug Coated Stent Sales by Country
3.6.2 Latin America Drug Coated Stent Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Drug Coated Stent Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug Coated Stent Sales by Country
3.7.2 Middle East and Africa Drug Coated Stent Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug Coated Stent Historic Market Analysis by Type
4.1 Global Drug Coated Stent Sales Market Share by Type (2017-2022)
4.2 Global Drug Coated Stent Revenue Market Share by Type (2017-2022)
4.3 Global Drug Coated Stent Price by Type (2017-2022)
5 Global Drug Coated Stent Historic Market Analysis by Application
5.1 Global Drug Coated Stent Sales Market Share by Application (2017-2022)
5.2 Global Drug Coated Stent Revenue Market Share by Application (2017-2022)
5.3 Global Drug Coated Stent Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Biosensors International
6.1.1 Biosensors International Corporation Information
6.1.2 Biosensors International Description and Business Overview
6.1.3 Biosensors International Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Biosensors International Drug Coated Stent Product Portfolio
6.1.5 Biosensors International Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Laboratories Drug Coated Stent Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Corporation Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Advantec Vascular Drug Coated Stent Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Corporation Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 B. Braun Drug Coated Stent Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Biosensors
6.5.1 Biosensors Corporation Information
6.5.2 Biosensors Description and Business Overview
6.5.3 Biosensors Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Biosensors Drug Coated Stent Product Portfolio
6.5.5 Biosensors Recent Developments/Updates
6.6 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Biotronik Drug Coated Stent Product Portfolio
6.6.5 Biotronik Recent Developments/Updates
6.7 Blue Medical
6.6.1 Blue Medical Corporation Information
6.6.2 Blue Medical Description and Business Overview
6.6.3 Blue Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Blue Medical Drug Coated Stent Product Portfolio
6.7.5 Blue Medical Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Boston Scientific Drug Coated Stent Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 DISA Vascular
6.9.1 DISA Vascular Corporation Information
6.9.2 DISA Vascular Description and Business Overview
6.9.3 DISA Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.9.4 DISA Vascular Drug Coated Stent Product Portfolio
6.9.5 DISA Vascular Recent Developments/Updates
6.10 Essen
6.10.1 Essen Corporation Information
6.10.2 Essen Description and Business Overview
6.10.3 Essen Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Essen Drug Coated Stent Product Portfolio
6.10.5 Essen Recent Developments/Updates
6.11 Medtronic Vascular
6.11.1 Medtronic Vascular Corporation Information
6.11.2 Medtronic Vascular Drug Coated Stent Description and Business Overview
6.11.3 Medtronic Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Medtronic Vascular Drug Coated Stent Product Portfolio
6.11.5 Medtronic Vascular Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Corporation Information
6.12.2 MicroPort Medical Drug Coated Stent Description and Business Overview
6.12.3 MicroPort Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.12.4 MicroPort Medical Drug Coated Stent Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Corporation Information
6.13.2 MIV Therapeutics Drug Coated Stent Description and Business Overview
6.13.3 MIV Therapeutics Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.13.4 MIV Therapeutics Drug Coated Stent Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Corporation Information
6.14.2 Orbusneich Drug Coated Stent Description and Business Overview
6.14.3 Orbusneich Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Orbusneich Drug Coated Stent Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Promed Medical
6.15.1 Promed Medical Corporation Information
6.15.2 Promed Medical Drug Coated Stent Description and Business Overview
6.15.3 Promed Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Promed Medical Drug Coated Stent Product Portfolio
6.15.5 Promed Medical Recent Developments/Updates
6.16 Relisys Medical
6.16.1 Relisys Medical Corporation Information
6.16.2 Relisys Medical Drug Coated Stent Description and Business Overview
6.16.3 Relisys Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Relisys Medical Drug Coated Stent Product Portfolio
6.16.5 Relisys Medical Recent Developments/Updates
6.17 Reva Medical
6.17.1 Reva Medical Corporation Information
6.17.2 Reva Medical Drug Coated Stent Description and Business Overview
6.17.3 Reva Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Reva Medical Drug Coated Stent Product Portfolio
6.17.5 Reva Medical Recent Developments/Updates
6.18 Sahajanand
6.18.1 Sahajanand Corporation Information
6.18.2 Sahajanand Drug Coated Stent Description and Business Overview
6.18.3 Sahajanand Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sahajanand Drug Coated Stent Product Portfolio
6.18.5 Sahajanand Recent Developments/Updates
6.19 Sino Medical
6.19.1 Sino Medical Corporation Information
6.19.2 Sino Medical Drug Coated Stent Description and Business Overview
6.19.3 Sino Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sino Medical Drug Coated Stent Product Portfolio
6.19.5 Sino Medical Recent Developments/Updates
6.20 Sorin
6.20.1 Sorin Corporation Information
6.20.2 Sorin Drug Coated Stent Description and Business Overview
6.20.3 Sorin Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Sorin Drug Coated Stent Product Portfolio
6.20.5 Sorin Recent Developments/Updates
6.21 Terumo Medical
6.21.1 Terumo Medical Corporation Information
6.21.2 Terumo Medical Drug Coated Stent Description and Business Overview
6.21.3 Terumo Medical Drug Coated Stent Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Terumo Medical Drug Coated Stent Product Portfolio
6.21.5 Terumo Medical Recent Developments/Updates
7 Drug Coated Stent Manufacturing Cost Analysis
7.1 Drug Coated Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug Coated Stent
7.4 Drug Coated Stent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug Coated Stent Distributors List
8.3 Drug Coated Stent Customers
9 Drug Coated Stent Market Dynamics
9.1 Drug Coated Stent Industry Trends
9.2 Drug Coated Stent Market Drivers
9.3 Drug Coated Stent Market Challenges
9.4 Drug Coated Stent Market Restraints
10 Global Market Forecast
10.1 Drug Coated Stent Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug Coated Stent by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Drug Coated Stent by Type (2023-2028)
10.2 Drug Coated Stent Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug Coated Stent by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Drug Coated Stent by Application (2023-2028)
10.3 Drug Coated Stent Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug Coated Stent by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Drug Coated Stent by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer